Santillan and associates also demonstrated that elevated maternal plasma copeptin is a significant predictor of preeclampsia as early as 6 weeks of pregnancy, improving care and potentially leading to the development of preventive measures [22]. The gene discussed is AVP; the disease is preeclampsia.